Identifying inhibitors of epithelial-mesenchymal transition by connectivity map-based systems approach.
about
Epithelial to Mesenchymal Transition in a Clinical PerspectiveEpithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistanceEpithelial-mesenchymal plasticity in carcinoma metastasisThe emerging molecular machinery and therapeutic targets of metastasisInvolvement of YAP, TAZ and HSP90 in contact guidance and intercellular junction formation in corneal epithelial cellsBRCA-Monet: a breast cancer specific drug treatment mode-of-action network for treatment effective prediction using large scale microarray database.Epithelial-mesenchymal transition-associated secretory phenotype predicts survival in lung cancer patients.Regional differences in susceptibiity of bronchial epithelium to mesenchymal transition and inhibition by the macrolide antibiotic azithromycin.Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugsA gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mappingMetformin, at concentrations corresponding to the treatment of diabetes, potentiates the cytotoxic effects of carboplatin in cultures of ovarian cancer cellsFSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness.Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition.Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition.Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung CancerPhthalazinone Pyrazole Enhances the Hepatic Functions of Human Embryonic Stem Cell-Derived Hepatocyte-Like Cells via Suppression of the Epithelial-Mesenchymal Transition.Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-specific immunosurveillance in lung cancer.The use of gene arrays and corresponding connectivity mapping (Cmap) to identify novel anti-ageing ingredients.Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis
P2860
Q26783554-5D0CB4A6-7937-4368-9D2D-9D7054286407Q26824386-A87908E7-D0BF-404A-8184-FAE12CFAD2BEQ26859804-5451CB94-1D53-44E4-91DC-E5319B008514Q27022207-44C585AD-A9C5-4F86-98B4-385AE8EB3CFCQ28543584-A005D85B-F154-4212-9675-7B1C98DB4024Q33643334-58C3AD84-14EB-428B-B08B-4486A4F00A3DQ33705213-CE4F1FDD-C174-47E4-96CE-749D333862EBQ34533624-4A54FD0C-BB08-4947-BF80-20C15329DEDCQ35823157-977E0F03-02A1-41EE-86F1-F4872D432DFCQ36015110-A732C534-FBD7-48FF-B0B3-4C13EA8E2171Q37280136-7BCC8A41-9875-4147-8311-7DEE9981CD47Q38431717-C0A714CE-148F-48C4-98E8-91C9F9F0ABE4Q38856280-C0836A29-A930-4E10-BB63-05879A31AAEFQ38953751-1DA10B56-75E2-4F7F-AF21-307F4BF9C5C7Q41552614-B1ABDF4B-6855-41A0-A0EE-99200FF2955CQ47251589-F1CBE556-297F-46CE-B190-6EE3358A3529Q50087304-059A9B82-5C50-4FA1-87EE-38ED6E86CDFCQ51012481-1EC44061-5210-453A-8C48-C24D4C63D4B4Q59136984-B2B7387B-101B-4497-AA9A-375B891D570B
P2860
Identifying inhibitors of epithelial-mesenchymal transition by connectivity map-based systems approach.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Identifying inhibitors of epit ...... ty map-based systems approach.
@en
type
label
Identifying inhibitors of epit ...... ty map-based systems approach.
@en
prefLabel
Identifying inhibitors of epit ...... ty map-based systems approach.
@en
P2093
P2860
P1476
Identifying inhibitors of epit ...... ty map-based systems approach.
@en
P2093
Ajaya Kumar Reka
Himabindu Kurapati
Rork Kuick
Theodore J Standiford
P2860
P304
P356
10.1097/JTO.0B013E31822ADFB0
P577
2011-11-01T00:00:00Z